They are constantly in initial test-mode and their antibody research and related patents are so far behind Gilead, ENZC, and Merck, that they won't be catching up for a profitable market release.
Halberd has always been in test mode. They test a scam and if it sells stock they run with that till is falters and then they test the next scam to sell stock.